Huiyuan Hou1, Takuhei Shoji2, Linda M Zangwill1, Sasan Moghimi3, Luke J Saunders1, Kyle Hasenstab1, Elham Ghahari1, Patricia Isabel C Manalastas1, Tadamichi Akagi4, Mark Christopher1, Rafaella C Penteado1, Robert N Weinreb5. 1. Hamilton Glaucoma Center and Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, California. 2. Hamilton Glaucoma Center and Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, California; Department of Ophthalmology, Saitama Medical University, Iruma, Saitama, Japan. 3. Hamilton Glaucoma Center and Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, California; Department of Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran. 4. Hamilton Glaucoma Center and Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, California; Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan. 5. Hamilton Glaucoma Center and Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, California. Electronic address: rweinreb@ucsd.edu.
Abstract
PURPOSE: To compare the rates of visual field (VF) loss and retinal nerve fiber layer (RNFL) thinning in primary open-angle glaucoma (POAG) patients with or without type 2 diabetes mellitus (DM). DESIGN: Cohort study. METHODS: A total of 197 eyes (55 eyes of 32 POAG patients with DM in POAG/DM group and 142 eyes of 111 age-matched POAG patients without DM in POAG/DM- group) were included from the Diagnostic Innovations in Glaucoma Study (DIGS). Type 2 DM participants were defined by self-report of DM history and use of antidiabetic medication. The rates of VF loss and RNFL loss were compared in POAG eyes with and without DM using univariate and multivariable mixed-effects models. RESULTS: The median (interquartile range) follow-up was 5.7 years (4.0, 6.4). The mean rate of global RNFL loss in the POAG/DM group was 2-fold slower than in the POAG/DM- group overall (-0.40 μm/year vs -0.83 μm/year, respectively P = .01). Although a slower rate of VF mean deviation and pattern standard deviation loss was found in the POAG/DM group compared to the POAG/DM- group, the difference was not statistically significant. CONCLUSIONS: POAG patients with treated type 2 DM, who had no detectable diabetic retinopathy, had significantly slower rates of RNFL thinning compared to those without diagnosed DM.
PURPOSE: To compare the rates of visual field (VF) loss and retinal nerve fiber layer (RNFL) thinning in primary open-angle glaucoma (POAG) patients with or without type 2 diabetes mellitus (DM). DESIGN: Cohort study. METHODS: A total of 197 eyes (55 eyes of 32 POAG patients with DM in POAG/DM group and 142 eyes of 111 age-matched POAG patients without DM in POAG/DM- group) were included from the Diagnostic Innovations in Glaucoma Study (DIGS). Type 2 DMparticipants were defined by self-report of DM history and use of antidiabetic medication. The rates of VF loss and RNFL loss were compared in POAG eyes with and without DM using univariate and multivariable mixed-effects models. RESULTS: The median (interquartile range) follow-up was 5.7 years (4.0, 6.4). The mean rate of global RNFL loss in the POAG/DM group was 2-fold slower than in the POAG/DM- group overall (-0.40 μm/year vs -0.83 μm/year, respectively P = .01). Although a slower rate of VF mean deviation and pattern standard deviation loss was found in the POAG/DM group compared to the POAG/DM- group, the difference was not statistically significant. CONCLUSIONS: POAG patients with treated type 2 DM, who had no detectable diabetic retinopathy, had significantly slower rates of RNFL thinning compared to those without diagnosed DM.
Authors: Vikas Chopra; Rohit Varma; Brian A Francis; Joanne Wu; Mina Torres; Stanley P Azen Journal: Ophthalmology Date: 2007-08-22 Impact factor: 12.079
Authors: Vincent Laville; Jae H Kang; Clara C Cousins; Adriana I Iglesias; Réka Nagy; Jessica N Cooke Bailey; Robert P Igo; Yeunjoo E Song; Daniel I Chasman; William G Christen; Peter Kraft; Bernard A Rosner; Frank Hu; James F Wilson; Puya Gharahkhani; Alex W Hewitt; David A Mackey; Pirro G Hysi; Christopher J Hammond; Cornelia M vanDuijn; Jonathan L Haines; Veronique Vitart; John H Fingert; Michael A Hauser; Hugues Aschard; Janey L Wiggs; Anthony P Khawaja; Stuart MacGregor; Louis R Pasquale Journal: Am J Ophthalmol Date: 2019-05-20 Impact factor: 5.258
Authors: Nicholas M Pfahler; Jordan L Barry; Indre E Bielskus; Agni Kakouri; Michael C Giovingo; Nicholas J Volpe; Paul A Knepper Journal: J Ophthalmol Date: 2020-06-08 Impact factor: 1.909
Authors: Andrzej Grzybowski; Mariusz Och; Piotr Kanclerz; Christopher Leffler; Carlos Gustavo De Moraes Journal: J Clin Med Date: 2020-03-11 Impact factor: 4.241